G
George Nuki
Researcher at University of Edinburgh
Publications - 77
Citations - 14088
George Nuki is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Gout & Chondrocyte. The author has an hindex of 38, co-authored 77 publications receiving 12915 citations. Previous affiliations of George Nuki include Northern General Hospital & Western General Hospital.
Papers
More filters
Journal ArticleDOI
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
Weiya Zhang,R W Moskowitz,George Nuki,S Abramson,R D Altman,Nigel K Arden,Sita M A Bierma-Zeinstra,K D Brandt,P Croft,Michael Doherty,Maxime Dougados,Marc C. Hochberg,David J. Hunter,K Kwoh,L S Lohmander,Peter Tugwell +15 more
TL;DR: Twenty-five carefully worded recommendations have been generated based on a critical appraisal of existing guidelines, a systematic review of research evidence and the consensus opinions of an international, multidisciplinary group of experts for the management of hip and knee osteoarthritis.
Journal ArticleDOI
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009
Weiya Zhang,George Nuki,Roland W. Moskowitz,S.B. Abramson,Roy D. Altman,Nigel K Arden,S.M.A. Bierma-Zeinstra,Kenneth D. Brandt,Peter Croft,Michael Doherty,Maxime Dougados,Marc C. Hochberg,David J. Hunter,Kent Kwoh,L.S. Lohmander,Peter Tugwell +15 more
TL;DR: In this paper, a systematic literature search was undertaken using MEDLINE, EMBASE, CINAHL, AMED, Science Citation Index and the Cochrane Library to examine whether research evidence has changed from 31 January 2006 to 31 January 2009.
Journal ArticleDOI
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
Weiya Zhang,M. Doherty,Thomas Bardin,Eliseo Pascual,V. Barskova,P.G. Conaghan,J Gerster,J Jacobs,Burkhard F. Leeb,Frédéric Lioté,Geraldine M. McCarthy,Patrick Netter,George Nuki,Fernando Perez-Ruiz,A Pignone,J. Pimentao,Leonardo Punzi,Edward Roddy,Till Uhlig,Irena Zimmermann-Górska +19 more
TL;DR: 12 key recommendations for management of gout were developed, using a combination of research based evidence and expert consensus, based on a Delphi consensus approach.
Journal ArticleDOI
Treatment of rheumatoid arthritis with recombinant human interleukin‐1 receptor antagonist
Barry Bresnihan,José María Álvaro-Gracia,Mark Cobby,Michael Doherty,Zlatko Domljan,Paul Emery,George Nuki,Karel Pavelka,Rolf Rau,Blaz Rozman,Iain Watt,Bryan D. Williams,Roger Aitchison,Dorothy McCabe,Predrag Musikic +14 more
TL;DR: IL-1Ra is the first biologic agent to demonstrate a beneficial effect on the rate of joint erosion and is confirmed both the efficacy and the safety in a large cohort of patients with active and severe RA.
Journal ArticleDOI
2016 updated EULAR evidence-based recommendations for the management of gout
Pascal Richette,Michael Doherty,Eliseo Pascual,V. Barskova,Fabio Becce,Johann Castañeda-Sanabria,M. Coyfish,S Guillo,T.L.Th.A. Jansen,Hein J.E.M. Janssens,Frédéric Lioté,Christian D Mallen,George Nuki,Fernando Perez-Ruiz,J. Pimentao,Leonardo Punzi,T Pywell,Alexander So,Anne-Kathrin Tausche,Till Uhlig,Jakub Zavada,Weiya Zhang,Florence Tubach,Thomas Bardin +23 more
TL;DR: In addition to education and a non-pharmacological management approach, urate-lowering therapy (ULT) should be considered from the first presentation of the disease, and serum uric acid (SUA) levels should be maintained at the predefined urate target to cure the disease.